Get started
Author

Yeşim Ağyol

Observed names: Y. Agyol, Y., Agyol, Yesim Agyol, Yesim Ağyol, Yesım Agyol, Yeşim AGYOL, Yeşim AĞYOL, Yeşim Ağyol1
ORCID: 0000-0002-4409-6003
Observed ORCID: 0000-0002-4409-6003
OpenAlex ID: A5093777828
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
2025 · Nadiye Sever, Fatih Şimşek, et al. · Journal of Clinical Medicine · 15
Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors
2025 · Ali Kaan Güren, Murad Guliyev, et al. · Journal of Clinical Medicine · 10
PDF
Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.
2025 · Nadiye Sever, Emil Yunusov, et al. · PubMed · 5
PDF
HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report
2024 · Ali Kaan Güren, Erkam Kocaaslan, et al. · Anti-Cancer Drugs · 5
The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy
2025 · Ali Kaan Güren, Zilan Başkan, et al. · Medicina · 3
PDF
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
2024 · Osman Köstek, Ahmet Demirel, et al. · Journal of Chemotherapy · 2
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience
2024 · Nargiz Majidova, Murat Sarı, et al. · Oncology Research and Treatment · 2
Capecitabine-induced pneumonitis: a rare case report and literature review
2026 · Mustafa A. Tunç, Ali K. Güren, et al. · Anti-Cancer Drugs · 1
Acquired CD74–ROS1 fusion–mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case report
2026 · Ali Kaan Güren, Erkam Kocaaslan, et al. · Journal of Chemotherapy · 1
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma
2026 · Burak Paçacı, Erkam Kocaaslan, et al. · Journal of Clinical Medicine · 1
PDF
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
2026 · Erkam Kocaaslan, Ali Kaan Güren, et al. · Journal of Clinical Medicine · 1
PDF
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab
2026 · Erkam Kocaaslan, Ali Kaan Güren, et al. · Medicina · 1
PDF
Upper extremity function and strength, assessed with unsupported upper limb exercise test, is impaired in patients with Takayasu arteritis
2025 · Fatma Temiz, Yeşim Ağyol, et al. · Modern Rheumatology · 1
Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study
2025 · Ali Kaan Güren, Hilal Polat, et al. · Annals of Saudi Medicine · 1
Survival Outcomes in Metastatic Germ Cell Tumors: A Multicenter Study from Turkey
2025 · Gul Sema Yildiran Keskin, Ozge Yetginoglu, et al. · Medicina · 1
PDF
Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience
2025 · Nadiye Sever, Emil Yunusov, et al. · Nutrition and Cancer · 1
The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis
2025 · Nadiye Sever, Sedat Yıldırım, et al. · Medicina · 1
PDF
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey
2024 · Nargiz Majidova, Shahla Aghamaliyeva, et al. · Journal of Chemotherapy · 1
Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study
2024 · Nargiz Majidova, Mustafa Seyyar, et al. · Biomolecules and Biomedicine · 1
Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors
2026 · Ezgi Çoban, Atilla Eren Kurt, et al. · Journal of Clinical Medicine
Digital health engagement and health literacy among cancer patients: a cross-sectional study of ICT usage patterns
2026 · Abdussamet Çelebi, Nur Aybüke Bircan, et al. · BMC Health Services Research
Diabetes Increases Immunotherapy‐Related Toxicity but Not Efficacy in Metastatic Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study
2026 · Emre Çakır, Didem Divriklioğlu, et al. · International Journal of Cancer
PDF
Prognostic Significance of Postoperative Edema in Surgically Treated Non-glioblastoma Diffuse Glioma
2026 · Erkam KOCAASLAN, Gülşah ÖZDEN, et al. · Journal of Oncological Sciences
PDF
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies
2026 · Mustafa Alperen Tunç, Ali Kaan Güren, et al. · Journal of Clinical Medicine
PDF
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study
2026 · Bahadır Köylü, Özde Melisa Celayir, et al. · Cancers
Works count: 44
Citation count: 54
H-index: 4
I10-index: 2
Year
Topic
Type